Zimmer Biomet Holdings announced an increase in its share repurchase target, aiming to buy back up to $1 billion in shares by the end of the year. Thi...
Neutral
KLCM Advisors Inc. significantly increased its stake in Zimmer Biomet Holdings, Inc. by 80.4% in the fourth quarter, purchasing an additional 58,427 s...
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) has increased its share repurchase expectations for fiscal year 2026 to up to $1 billion, representing a $250...
Bullish
Zimmer Biomet Holdings Inc (ZBH) saw its shares decline by 3.3% to $79.58, placing it significantly below its GF Value™ of $126.46, indicating it is u...
Neutral
Bryn Mawr Trust Advisors LLC reduced its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 39% in the fourth quarter, selling 25,448 shares and reta...
Neutral
Sequoia Financial Advisors LLC reduced its stake in Zimmer Biomet Holdings, Inc. by 19.9% in the fourth quarter, selling 16,194 shares and retaining 6...
Neutral
Zimmer Biomet reported better-than-expected Q1 2026 results, with revenue of $1.64 billion and adjusted EPS of $1.18, leading the orthopedic device ma...
Bullish
Wall Street Zen upgraded Zimmer Biomet (NYSE:ZBH) from a "hold" to a "buy" rating, despite the stock having a consensus "Hold" rating from other analy...
Vanguard Capital Management has filed a Schedule 13G reporting a 7.54% beneficial ownership in Zimmer Biomet Holdings Inc (ZBH), totaling 14,767,527 c...
Neutral
Cwm LLC significantly reduced its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 60.8% in Q4, selling 14,532 shares and leaving them with 9,377 s...
Bullish
Zimmer Biomet Holdings Inc reported a strong start to 2026 with a 9.3% increase in revenue to $2.087 billion and a 15% rise in adjusted EPS to $2.09. ...
Bearish
Zimmer Biomet (ZBH) saw its stock plunge to a 13-year low despite strong Q1 earnings, following the immediate resignation of its CFO, Suketu Upadhyay....
Neutral
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has received a consensus "Hold" recommendation from analysts, with an average 12-month price target of approxi...
Neutral
Boston Trust Walden Corp reduced its stake in Zimmer Biomet Holdings, Inc. by 3.5% in the fourth quarter. Despite this, Zimmer Biomet reported strong ...
Bullish
Indiana University and Zimmer Biomet have formed a strategic partnership to accelerate technology development in orthopedics, aiming to reduce the tim...
Neutral
This report evaluates Zimmer Biomet's business model, focusing on its dominance in orthopedic devices like hips, knees, and robotic systems, and its r...
Bullish
Google's 2026 Discover Core Update, completed on February 27, 2026, is profoundly changing how financial news, including insights on Zimmer Biomet Hol...
Neutral
Wall Street Zen downgraded Zimmer Biomet (NYSE:ZBH) from a "buy" to a "hold" rating. Despite the downgrade, Zimmer Biomet recently surpassed Q4 earnin...
Bullish
Zimmer Biomet Holdings, Inc. announced FDA 510(k) clearance for an expanded line of its Identity and Comprehensive Reverse Shoulder Systems. This expa...